Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rpb1 CTD Antikörper (pTyr1)

Es sind 4+ Publikationen für dieses Produkt verfügbar. Der Ratte Monoklonal anti-Rpb1 CTD Antikörper wird verwendet zum Nachweis von Rpb1 CTD in Proben von Human. Er wurde validiert für WB, IF, ICC, ChIP und IP.
Produktnummer ABIN2668519
752,31 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 2 bis 4 Werktagen

Kurzübersicht für Rpb1 CTD Antikörper (pTyr1) (ABIN2668519)

Target

Rpb1 CTD (RNA Polymerase II CTD)

Reaktivität

  • 25
  • 7
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 10
  • 9
  • 6
Ratte

Klonalität

  • 16
  • 9
Monoklonal

Konjugat

  • 21
  • 4
Dieser Rpb1 CTD Antikörper ist unkonjugiert

Applikation

  • 25
  • 19
  • 15
  • 9
  • 9
  • 5
  • 4
  • 3
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC), Chromatin Immunoprecipitation (ChIP), Immunoprecipitation (IP)

Klon

3D12
  • Bindungsspezifität

    • 9
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr1

    Verwendungszweck

    RNA pol II CTD phospho Tyr1 antibody (mAb) (Clone 3D12)

    Aufreinigung

    Protein G Chromatography

    Immunogen

    This antibody was raised against a synthetic peptide containing the RNA Pol II heptad repeat consensus sequence phosphorylated at tyrosine 1.

    Isotyp

    IgG1
  • Applikationshinweise

    WB*: 1 - 2 μg/mL *Note: Many chromatin-bound proteins are not soluble in a low salt nuclear extract and fractionate to the pellet. Therefore, we recommend a High Salt / Sonication Protocol when preparing nuclear extracts for Western blot. In addition, we recommend the addition of 0.05 % Tween 20 to all blocking solutions to reduce background. This antibody is also available as an AbFlex engineered recombinant antibody. For details on the corresponding AbFlex Recombinant Antibody, see Catalog No. 91219.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 μg/μL

    Buffer

    Purified IgG in PBS with 30 % glycerol and 0.035 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions,Keep all reagents on ice when not in storage

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Some products may be shipped at room temperature. This will not affect their stability or performance. Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.

    Haltbarkeit

    24 months
  • Harlen, Trotta, Smith, Mosaheb, Fuchs, Churchman: "Comprehensive RNA Polymerase II Interactomes Reveal Distinct and Varied Roles for Each Phospho-CTD Residue." in: Cell reports, Vol. 15, Issue 10, pp. 2147-2158, (2016) (PubMed).

    Laitem, Zaborowska, Isa, Kufs, Dienstbier, Murphy: "CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes." in: Nature structural & molecular biology, Vol. 22, Issue 5, pp. 396-403, (2015) (PubMed).

    Zaborowska, Baumli, Laitem, OReilly, Thomas, OHare, Murphy: "Herpes Simplex Virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongation." in: PLoS ONE, Vol. 9, Issue 9, pp. e107654, (2014) (PubMed).

    Mayer, Heidemann, Lidschreiber, Schreieck, Sun, Hintermair, Kremmer, Eick, Cramer: "CTD tyrosine phosphorylation impairs termination factor recruitment to RNA polymerase II." in: Science (New York, N.Y.), Vol. 336, Issue 6089, pp. 1723-5, (2012) (PubMed).

  • Target

    Rpb1 CTD (RNA Polymerase II CTD)

    Andere Bezeichnung

    RNA Pol II CTD

    Hintergrund

    RNA pol II (RNA polymerase II) is responsible for synthesizing messenger RNA in eukaryotes. RNA pol II contains a carboxy terminal domain composed of heptapeptide repeats that are essential for polymerase activity. These repeats contain serine and threonine residues that are phosphorylated in actively transcribing RNA polymerase. In addition, RNA pol II, in combination with several other polymerase subunits, form the DNA binding domain of the polymerase, a groove in which the DNA template is transcribed into RNA. During the transcription cycle, the CTD of the large subunit of RNA pol II is reversibly phosphorylated. RNA pol II containing unphosphorylated CTD is recruited to the promoter, whereas the hyperphosphorylated CTD form is involved in active transcription. Phosphorylation occurs at sites within the heptapeptide repeat, at serine 2, serine 5, serine 7 and tyrosine 1. RNA pol II Tyrosine 1 phosphorylation is found during elongation and appears to activate transcription by suppressing RNA pol II termination.

    Molekulargewicht

    210 kDa

    Gen-ID

    5430

    NCBI Accession

    NP_000928
Sie sind hier:
Chat with us!